6/5
07:57 am
imux
When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven? [Yahoo! Finance]
Low
Report
When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven? [Yahoo! Finance]
5/28
06:33 am
imux
Immunic to Participate in Industry and Scientific Conferences in June [Yahoo! Finance]
Medium
Report
Immunic to Participate in Industry and Scientific Conferences in June [Yahoo! Finance]
5/28
06:30 am
imux
Immunic to Participate in Industry and Scientific Conferences in June
Neutral
Report
Immunic to Participate in Industry and Scientific Conferences in June
5/9
10:30 am
imux
Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/9
07:17 am
imux
We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Low
Report
We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully [Yahoo! Finance]
5/8
06:46 am
imux
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
5/8
06:30 am
imux
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
5/6
06:38 am
imux
Immunic to Participate in Investor and Scientific Conferences in May [Yahoo! Finance]
Medium
Report
Immunic to Participate in Investor and Scientific Conferences in May [Yahoo! Finance]
5/6
06:30 am
imux
Immunic to Participate in Investor and Scientific Conferences in May
Medium
Report
Immunic to Participate in Investor and Scientific Conferences in May
5/1
10:11 am
imux
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal [Yahoo! Finance]
Medium
Report
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal [Yahoo! Finance]
5/1
06:42 am
imux
Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update [Yahoo! Finance]
Medium
Report
Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update [Yahoo! Finance]
5/1
06:30 am
imux
Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
Medium
Report
Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
4/30
06:40 am
imux
Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation [Yahoo! Finance]
Neutral
Report
Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation [Yahoo! Finance]
4/30
06:30 am
imux
Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation
Low
Report
Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation
4/29
11:22 am
imux
Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role [Yahoo! Finance]
Medium
Report
Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role [Yahoo! Finance]
4/27
02:05 am
imux
Immunic, Inc. (NASDAQ: IMUX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Immunic, Inc. (NASDAQ: IMUX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
4/19
11:01 pm
imux
Immunic, Inc. (NASDAQ: IMUX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Immunic, Inc. (NASDAQ: IMUX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
4/5
08:38 am
imux
ATOS, SMR and EIGR are among pre market gainers [Seeking Alpha]
Medium
Report
ATOS, SMR and EIGR are among pre market gainers [Seeking Alpha]
4/5
08:03 am
imux
Immunic, Inc. (NASDAQ: IMUX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Immunic, Inc. (NASDAQ: IMUX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $10.00 price target on the stock.
4/4
08:10 am
imux
With 44% ownership, Immunic, Inc. (NASDAQ:IMUX) has piqued the interest of hedge funds investors [Yahoo! Finance]
Low
Report
With 44% ownership, Immunic, Inc. (NASDAQ:IMUX) has piqued the interest of hedge funds investors [Yahoo! Finance]
4/4
06:34 am
imux
Immunic to Host MS R&D Day and Participate in Investor Conferences in April [Yahoo! Finance]
Low
Report
Immunic to Host MS R&D Day and Participate in Investor Conferences in April [Yahoo! Finance]
4/4
06:30 am
imux
Immunic to Host MS R&D Day and Participate in Investor Conferences in April
Low
Report
Immunic to Host MS R&D Day and Participate in Investor Conferences in April
3/29
11:08 pm
imux
Immunic, Inc. (NASDAQ: IMUX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Neutral
Report
Immunic, Inc. (NASDAQ: IMUX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/21
12:33 pm
imux
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month [Yahoo! Finance]
Low
Report
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month [Yahoo! Finance]
3/21
11:46 am
imux
Immunic secures key patent, boosting MS drug exclusivity and global IP strategy [Yahoo! Finance]
Low
Report
Immunic secures key patent, boosting MS drug exclusivity and global IP strategy [Yahoo! Finance]